Statin Therapy in Patients with Type 2 Diabetes Mellitus in Hungary
Journal Title: Cardiology and Angiology: An International Journal - Year 2015, Vol 4, Issue 4
Abstract
Aim: The benefit of statin administration in the secondary prevention of cardiovascular diseases in type 2 diabetes mellitus (T2DM) is well documented. The aim of the study was to evaluate the characteristics of lipid lowering therapy and the attainment of target values. Study Design: Retrospective data analysis. Place and Duration of Study: Between 2009 and 2011, Hungary. Methodology: The study was conducted on the patients with T2DM and established cardiovascular events of general practitioners and specialists from the MULTI GAP (MULTI Goal Attainment Problem) survey in Hungary using standardized, structured questionnaires. Data collection was performed in 2009 (1582 patients, 55.0% men), in 2010 (1159 patients, 58.4% men) and in 2011 (668 patients, 59.1% men). Results: In this study all patients received statins, the most frequently used was atorvastatin, followed in 2009 by simvastatin and 2011 by rosuvastatin. Fibrates were taken by 9.3–11.3% of patients and ezetimibe by 8.0–15.9% of patients. The total cholesterol (TC) values in 2009, in 2010 and in 2011 were 5.27±1.23 mmol/l, 4.90±1.30 mmol/l, 4.88±1.29 mmol/l, respectively (p>0.05). The LDL-cholesterol (LDL-C) values were 2.94±1.04 mmol/l, 2.73±0.95 mmol/l, 2.69±1.03 mmol/l, respectively (p>0.05). The proportion of patients at LDL-C target value of <2.5 mmol/l was 35.2%, 42.8%, 47.8% (p<0.001 vs values in 2009) while that of <1.8 mmol/l was 10.6%, 15.9% and 16.8%, respectively (p<0.001 vs values in 2009). There was a linear correlation between the patient compliance estimated by the physicians and the LDL-C achievement rate. Conclusions: In 2009-2011, a slight improvement in serum cholesterol levels and a significant increase of patients at target TC or LDL-C values were documented among patients with T2DM and cardiovascular diseases. Nevertheless, the authors find very important to improve the quality of lipid lowering treatment in order to increase the number of patients achieving their target lipid values.
Authors and Affiliations
Laszlo Mark, Istvan Reiber, György Paragh, Gyula Pados, Zoltan Kiss
Keywords
Related Articles
- EP ID EP344083
- DOI 10.9734/CA/2015/22424
- Views 82
- Downloads 0
Infantile Cardiac Rhabdomyoma–Pearls Inside the Heart
Cardiac rhabdomyoma is the most common primary pediatric tumor of the heart. We report a 1-month old male infant who presented to our institute for routine cardiac evaluation since he was diagnosed to have a cardiac mass...
Recanalization of TASC C/D Iliac Occlusion: An Improved Technique through the Radio-brachial Access
We describe a technique for reanalyzing total chronic long occlusion of the iliac arteries (TASC/D) through the radio-brachial approach. After having obtained the arterial approach, a 6F 90cm long Shuttle sheath (Cook G...
No Synergic Effect of Sildenafil Administration on Exercise Capacity Improvement in a Fontan Patient with Regular Exercise Training
In Fontan patients, reduced exercise capacity due to diminished cardiac output is a common finding with important prognostic implications. Beneficial effects have been shown for sildenafil treatment and regular exercise,...
Effect of an Increase in Global Left Ventricular Afterload on Myocardial Deformation in Patients with Aortic Stenosis, Comparison with Hypertensive Patients
Aims: Left ventricular hypertrophy (LVH) secondary to hypertension and aortic stenosis (AS) are often considered together to be pressure overload hypertrophy. We hypothesized that important differences could e...
About Physical Bases of Heart Acting. Case of Healthy Women in Democratic Republic of Congo
Background: The hypertension is probably the most important public health problem in our country. It is readily detectable and often leads to lethal complications such as heart failure if left untreated. Indeed among the...